-
1
-
-
84922381210
-
Heart disease and stroke statistics—2015 update: a report from the American Heart Association
-
1 Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 131 (2015), e29–322, 10.1161/CIR.0000000000000152.
-
(2015)
Circulation
, vol.131
, pp. e29-322
-
-
Mozaffarian, D.1
Benjamin, E.J.2
Go, A.S.3
Arnett, D.K.4
Blaha, M.J.5
Cushman, M.6
-
2
-
-
0033994772
-
The economic burden of heart failure
-
2 O'Connell, J.B., The economic burden of heart failure. Clin Cardiol 23 (2000), III-6–10, 10.1002/clc.4960231503.
-
(2000)
Clin Cardiol
, vol.23
, pp. III-6-10
-
-
O'Connell, J.B.1
-
3
-
-
6444239869
-
Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification
-
3 Perna, E.R., Macin, S.M., Canella, J.P., Augier, N., Stival, J.L., Cialzeta, J.R., et al. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Circulation 110 (2004), 2376–2382, 10.1161/01.CIR.0000145158.33801.F3.
-
(2004)
Circulation
, vol.110
, pp. 2376-2382
-
-
Perna, E.R.1
Macin, S.M.2
Canella, J.P.3
Augier, N.4
Stival, J.L.5
Cialzeta, J.R.6
-
4
-
-
84875766051
-
B-Type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction
-
4 van Veldhuisen, D.J., Linssen, G.C., Jaarsma, T., van Gilst, W.H., Hoes, A.W., Tijssen, J.G., et al. B-Type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol 61 (2013), 1498–1506, 10.1016/j.jacc.2012.12.044.
-
(2013)
J Am Coll Cardiol
, vol.61
, pp. 1498-1506
-
-
van Veldhuisen, D.J.1
Linssen, G.C.2
Jaarsma, T.3
van Gilst, W.H.4
Hoes, A.W.5
Tijssen, J.G.6
-
5
-
-
79955943158
-
High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure
-
5 Ky, B., French, B., McCloskey, K., Rame, J.E., McIntosh, E., Shahi, P., et al. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ Heart Fail 4 (2011), 180–187, 10.1161/CIRCHEARTFAILURE.110.958223.
-
(2011)
Circ Heart Fail
, vol.4
, pp. 180-187
-
-
Ky, B.1
French, B.2
McCloskey, K.3
Rame, J.E.4
McIntosh, E.5
Shahi, P.6
-
6
-
-
1542343883
-
Extracellular functions of galectin-3
-
6 Ochieng, J., Furtak, V., Lukyanov, P., Extracellular functions of galectin-3. Glycoconj J 19 (2004), 527–535, 10.1023/B:GLYC.0000014082.99675.2f.
-
(2004)
Glycoconj J
, vol.19
, pp. 527-535
-
-
Ochieng, J.1
Furtak, V.2
Lukyanov, P.3
-
7
-
-
33745006606
-
Galectin-3: an open-ended story
-
7 Dumic, J., Dabelic, S., Flogel, M., Galectin-3: an open-ended story. Biochim Biophys Acta 1760 (2006), 616–635, 10.1016/j.bbagen.2005.12.020.
-
(2006)
Biochim Biophys Acta
, vol.1760
, pp. 616-635
-
-
Dumic, J.1
Dabelic, S.2
Flogel, M.3
-
8
-
-
33645533798
-
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
-
8 Henderson, N.C., Mackinnon, A.C., Farnworth, S.L., Poirier, F., Russo, F.P., Iredale, J.P., et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A 103 (2006), 5060–5065, 10.1073/pnas.0511167103.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 5060-5065
-
-
Henderson, N.C.1
Mackinnon, A.C.2
Farnworth, S.L.3
Poirier, F.4
Russo, F.P.5
Iredale, J.P.6
-
9
-
-
61949375975
-
N-Acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
-
9 Liu, Y.H., d'Ambrosio, M., Liao, T.D., Peng, H., Rhaleb, N.E., Sharma, U., et al. N-Acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin. Am J Physiol Heart Circ Physiol 296 (2009), H404–12, 10.1152/ajpheart.00747.2008.
-
(2009)
Am J Physiol Heart Circ Physiol
, vol.296
, pp. H404-12
-
-
Liu, Y.H.1
d'Ambrosio, M.2
Liao, T.D.3
Peng, H.4
Rhaleb, N.E.5
Sharma, U.6
-
10
-
-
77449109919
-
Galectin-3 in cardiac remodeling and heart failure
-
10 de Boer, R.A., Yu, L., van Veldhuisen, D.J., Galectin-3 in cardiac remodeling and heart failure. Curr Heart Fail Rep 7 (2010), 1–8, 10.1007/s11897-010-0004-x.
-
(2010)
Curr Heart Fail Rep
, vol.7
, pp. 1-8
-
-
de Boer, R.A.1
Yu, L.2
van Veldhuisen, D.J.3
-
11
-
-
20844462878
-
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction
-
11 Sharma, U.C., Pokharel, S., van Brakel, T.J., van Berlo, J.H., Cleutjens, J.P., Schroen, B., et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110 (2004), 3121–3128, 10.1161/01.CIR.0000147181.65298.4D.
-
(2004)
Circulation
, vol.110
, pp. 3121-3128
-
-
Sharma, U.C.1
Pokharel, S.2
van Brakel, T.J.3
van Berlo, J.H.4
Cleutjens, J.P.5
Schroen, B.6
-
12
-
-
84902298336
-
Comprehensive review of the prognostic value of galectin-3 in heart failure
-
12 Coburn, E., Frishman, W., Comprehensive review of the prognostic value of galectin-3 in heart failure. Cardiol Rev 22 (2014), 171–175, 10.1097/CRD.0000000000000013.
-
(2014)
Cardiol Rev
, vol.22
, pp. 171-175
-
-
Coburn, E.1
Frishman, W.2
-
13
-
-
79960350455
-
Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival
-
13 Tang, W.H., Shrestha, K., Shao, Z., Borowski, A.G., Troughton, R.W., Thomas, J.D., et al. Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival. Am J Cardiol 108 (2011), 385–390, 10.1016/j.amjcard.2011.03.056.
-
(2011)
Am J Cardiol
, vol.108
, pp. 385-390
-
-
Tang, W.H.1
Shrestha, K.2
Shao, Z.3
Borowski, A.G.4
Troughton, R.W.5
Thomas, J.D.6
-
14
-
-
79960555230
-
Galectin-3 in heart failure: high levels are associated with all-cause mortality
-
14 Ueland, T., Aukrust, P., Broch, K., Aakhus, S., Skardal, R., Muntendam, P., et al. Galectin-3 in heart failure: high levels are associated with all-cause mortality. Int J Cardiol 150 (2011), 361–364, 10.1016/j.ijcard.2011.05.081.
-
(2011)
Int J Cardiol
, vol.150
, pp. 361-364
-
-
Ueland, T.1
Aukrust, P.2
Broch, K.3
Aakhus, S.4
Skardal, R.5
Muntendam, P.6
-
15
-
-
84555204713
-
Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial
-
15 Lopez-Andrès, N., Rossignol, P., Iraqi, W., Fay, R., Nuée, J., Ghio, S., et al. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. Eur J Heart Fail 14 (2012), 74–81, 10.1093/eurjhf/hfr151.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 74-81
-
-
Lopez-Andrès, N.1
Rossignol, P.2
Iraqi, W.3
Fay, R.4
Nuée, J.5
Ghio, S.6
-
16
-
-
77954658143
-
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the Deal-HF study
-
16 Lok, D.J., van der Meer, P., de la Porte, P.W., Lipsic, E., van Wijngaarden, J., Hillege, H.L., et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the Deal-HF study. Clin Res Cardiol 99 (2010), 323–328, 10.1007/s00392-010-0125-y.
-
(2010)
Clin Res Cardiol
, vol.99
, pp. 323-328
-
-
Lok, D.J.1
van der Meer, P.2
de la Porte, P.W.3
Lipsic, E.4
van Wijngaarden, J.5
Hillege, H.L.6
-
17
-
-
84859639923
-
Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study
-
17 Felker, G.M., Fiuzat, M., Shaw, L.K., Clare, R., Whellan, D.J., Bettari, L., et al. Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study. Circ Heart Fail 5 (2012), 72–88, 10.1161/CIRCHEARTFAILURE.111.963637.
-
(2012)
Circ Heart Fail
, vol.5
, pp. 72-88
-
-
Felker, G.M.1
Fiuzat, M.2
Shaw, L.K.3
Clare, R.4
Whellan, D.J.5
Bettari, L.6
-
18
-
-
84887625229
-
Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction
-
18 Carrasco-Sánchez, F.J., Aramburu-Bodas, O., Salamanca-Bautista, P., Morales-Rull, J.L., Galisteo-Almeda, L., Páez-Rubio, M.I., et al. Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction. Int J Cardiol 169 (2013), 177–182, 10.1016/j.ijcard.2013.08.081.
-
(2013)
Int J Cardiol
, vol.169
, pp. 177-182
-
-
Carrasco-Sánchez, F.J.1
Aramburu-Bodas, O.2
Salamanca-Bautista, P.3
Morales-Rull, J.L.4
Galisteo-Almeda, L.5
Páez-Rubio, M.I.6
-
19
-
-
84901658442
-
Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure
-
19 Ahmad, T., Fiuzat, M., Neely, B., Neely, M.L., Pencina, M.J., Kraus, W.E., et al. Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure. JACC Heart Fail 2 (2014), 260–268, 10.1016/j.jchf.2013.12.004.
-
(2014)
JACC Heart Fail
, vol.2
, pp. 260-268
-
-
Ahmad, T.1
Fiuzat, M.2
Neely, B.3
Neely, M.L.4
Pencina, M.J.5
Kraus, W.E.6
-
20
-
-
84892415130
-
Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3
-
20 Bayes-Genis, A., de Antonio, M., Vila, J., Peñafiel, J., Galán, A., Barallat, J., et al. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3. J Am Coll Cardiol 63 (2014), 158–166, 10.1016/j.jacc.2013.07.087.
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. 158-166
-
-
Bayes-Genis, A.1
de Antonio, M.2
Vila, J.3
Peñafiel, J.4
Galán, A.5
Barallat, J.6
-
21
-
-
78651387589
-
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
-
21 de Boer, R.A., Lok, D.J., Jaarsma, T., van der Meer, P., Voors, A.A., Hillege, H.L., et al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med 43 (2011), 60–68, 10.3109/07853890.2010.538080.
-
(2011)
Ann Med
, vol.43
, pp. 60-68
-
-
de Boer, R.A.1
Lok, D.J.2
Jaarsma, T.3
van der Meer, P.4
Voors, A.A.5
Hillege, H.L.6
-
22
-
-
84902258897
-
Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes
-
22 Basuray, A., French, B., Ky, B., Vorovich, E., Olt, C., Sweitzer, N.K., et al. Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes. Circulation 129 (2014), 2380–2387, 10.1161/CIRCULATIONAHA.113.006855.
-
(2014)
Circulation
, vol.129
, pp. 2380-2387
-
-
Basuray, A.1
French, B.2
Ky, B.3
Vorovich, E.4
Olt, C.5
Sweitzer, N.K.6
-
23
-
-
84897017376
-
Analytical evaluation of the automated galectin-3 assay on the Abbott Architect immunoassay instruments
-
23 Gaze, D.C., Prante, C., Dreier, J., Knabbe, C., Collet, C., Launay, J.M., et al. Analytical evaluation of the automated galectin-3 assay on the Abbott Architect immunoassay instruments. Clin Chem Lab Med 52 (2014), 919–926, 10.1515/cclm-2013-0942.
-
(2014)
Clin Chem Lab Med
, vol.52
, pp. 919-926
-
-
Gaze, D.C.1
Prante, C.2
Dreier, J.3
Knabbe, C.4
Collet, C.5
Launay, J.M.6
-
24
-
-
84860797764
-
Multiple biomarkers for risk prediction in chronic heart failure
-
24 Ky, B., French, B., Levy, W.C., Sweitzer, N.K., Fang, J.C., Wu, A.H., et al. Multiple biomarkers for risk prediction in chronic heart failure. Circ Heart Fail 5 (2012), 183–190, 10.1161/CIRCHEARTFAILURE.111.965020.
-
(2012)
Circ Heart Fail
, vol.5
, pp. 183-190
-
-
Ky, B.1
French, B.2
Levy, W.C.3
Sweitzer, N.K.4
Fang, J.C.5
Wu, A.H.6
-
25
-
-
0033936550
-
Time-dependent ROC curves for censored survival data and a diagnostic marker
-
25 Heagerty, P.J., Lumley, T., Pepe, M.S., Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56 (2000), 337–344, 10.1111/j.0006-341X.2000.00337.x.
-
(2000)
Biometrics
, vol.56
, pp. 337-344
-
-
Heagerty, P.J.1
Lumley, T.2
Pepe, M.S.3
-
26
-
-
84866729958
-
Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community
-
26 Ho, J.E., Liu, C., Lyass, A., Courchesne, P., Pencina, M.J., Vasan, R.S., et al. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol 60 (2012), 1249–1256, 10.1016/j.jacc.2012.04.053.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 1249-1256
-
-
Ho, J.E.1
Liu, C.2
Lyass, A.3
Courchesne, P.4
Pencina, M.J.5
Vasan, R.S.6
-
27
-
-
84922956288
-
Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial
-
27 Edelmann, F., Holzendorf, V., Wachter, R., Nolte, K., Schmidt, A.G., Kraigher-Krainer, E., et al. Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial. Eur J Heart Fail 17 (2015), 214–223, 10.1002/ejhf.203.
-
(2015)
Eur J Heart Fail
, vol.17
, pp. 214-223
-
-
Edelmann, F.1
Holzendorf, V.2
Wachter, R.3
Nolte, K.4
Schmidt, A.G.5
Kraigher-Krainer, E.6
-
28
-
-
84897534300
-
Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction
-
28 Mohammed, S.F., Mirzoyev, S.A., Edwards, W.D., Dogan, A., Grogan, D.R., Dunlay, S.M., et al. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2 (2014), 113–122, 10.1016/j.jchf.2013.11.004.
-
(2014)
JACC Heart Fail
, vol.2
, pp. 113-122
-
-
Mohammed, S.F.1
Mirzoyev, S.A.2
Edwards, W.D.3
Dogan, A.4
Grogan, D.R.5
Dunlay, S.M.6
-
29
-
-
0037432301
-
Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
-
29 Anand, I.S., Fisher, L.D., Chiang, Y.T., Latini, R., Masson, S., Maggioni, A.P., et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107 (2003), 1278–1283, 10.1161/01.CIR.0000054164.99881.00.
-
(2003)
Circulation
, vol.107
, pp. 1278-1283
-
-
Anand, I.S.1
Fisher, L.D.2
Chiang, Y.T.3
Latini, R.4
Masson, S.5
Maggioni, A.P.6
-
30
-
-
70349983577
-
Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure
-
30 Miller, W.L., Hartman, K.A., Burritt, M.F., Grill, D.E., Jaffe, A.S., Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. J Am Coll Cardiol 54 (2009), 1715–1721, 10.1016/j.jacc.2009.07.025.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 1715-1721
-
-
Miller, W.L.1
Hartman, K.A.2
Burritt, M.F.3
Grill, D.E.4
Jaffe, A.S.5
-
31
-
-
84922751256
-
Letter by Psaty et al regarding article, “Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes”
-
31 Psaty, B.M., Shah, S.J., Gottdiener, J., Letter by Psaty et al regarding article, “Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes”. Circulation, 131, 2015, e343, 10.1161/CIRCULATIONAHA.114.012243.
-
(2015)
Circulation
, vol.131
, pp. e343
-
-
Psaty, B.M.1
Shah, S.J.2
Gottdiener, J.3
-
32
-
-
84922702448
-
Response to letter regarding article, “Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes
-
32 Basuray, A., French, B., Ky, B., Vorovich, E., Olt, C., Sweitzer, N., et al. Response to letter regarding article, “Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes. Circulation, 131, 2015, e344, 10.1161/CIRCULATIONAHA.114.012888.
-
(2015)
Circulation
, vol.131
, pp. e344
-
-
Basuray, A.1
French, B.2
Ky, B.3
Vorovich, E.4
Olt, C.5
Sweitzer, N.6
|